Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
RCT	348 children aged 12–17 years with moderate or severe headache pain (the intention-to-treat population consisted of 274 [80%] participants who completed treatment consistent with the study protocol)	Adverse effects (including somnolence and dizziness) 43% with eletriptan 28% with placebo Absolute numbers not reported	Significance not assessed P value not reported